Massive study aims to uncover cancer secrets in rare bone marrow diseases

NCT ID NCT00027274

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 8 times

Summary

This natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those who develop cancer from those who don't. The goal is to improve cancer screening and prevention for these high-risk groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify genetic and environmental factors that increase cancer risk in these families, pointing toward better screening and prevention strategies.
What could go wrong
This is an observational study, not a treatment trial. It may take many years to gather enough data, and findings may not apply to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMEGAKARYOCYTIC THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Cancer Institute - Shady Grove

    RECRUITING

    Rockville, Maryland, 20850, United States

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.